Ciprofloxacin for the Prevention of Postoperative Endoscopic Recurrence in Crohn's Disease

NCT00609973 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Crohn's Disease

Interventions

DRUG: Ciprofloxacin
DRUG: Placebo

Sponsor

University of North Carolina, Chapel Hill

Collaborators

[object Object]
[object Object]